These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34167853)

  • 1. Immunization effect of lipopolysaccharide antigen in conjugation with PLGA nanoparticles as a nanovaccine against Brucella melitensis infection.
    Maleki M; Salouti M
    Biologicals; 2021 Jul; 72():10-17. PubMed ID: 34167853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of a nanovaccine against
    Maleki M; Salouti M; Shafiee Ardestani M; Talebzadeh A
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4248-4256. PubMed ID: 31718300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK).
    Hoover DL; Crawford RM; Van De Verg LL; Izadjoo MJ; Bhattacharjee AK; Paranavitana CM; Warren RL; Nikolich MP; Hadfield TL
    Infect Immun; 1999 Nov; 67(11):5877-84. PubMed ID: 10531243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine.
    Bhattacharjee AK; Izadjoo MJ; Zollinger WD; Nikolich MP; Hoover DL
    Infect Immun; 2006 Oct; 74(10):5820-5. PubMed ID: 16988260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection.
    Sadeghi Z; Fasihi-Ramandi M; Azizi M; Bouzari S
    J Biotechnol; 2020 Feb; 310():89-96. PubMed ID: 32017955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The candidate vaccine strain Brucella ovis ∆abcBA is protective against Brucella melitensis infection in mice.
    Costa LF; Cabello AL; Batista DFA; Chaki SP; de Figueiredo P; da Paixão TA; Rice-Ficht AC; Ficht TA; Santos RL
    Microbiol Immunol; 2020 Nov; 64(11):730-736. PubMed ID: 32965738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB/c mice.
    Nazifi N; Tahmoorespur M; Sekhavati MH; Haghparast A; Behroozikhah AM
    BMC Vet Res; 2019 Nov; 15(1):402. PubMed ID: 31703683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
    Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
    Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of recombinant Omp25 or EipB protein loaded PLGA nanovaccines for Brucellosis protection.
    Akmayan I; Oztav S; Coksu I; Abamor ES; Acar S; Ozbek T
    Nanotechnology; 2024 Jul; 35(39):. PubMed ID: 38917779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rough brucella strain RM57 is attenuated and confers protection against Brucella melitensis.
    Feng Y; Peng X; Jiang H; Peng Y; Zhu L; Ding J
    Microb Pathog; 2017 Jun; 107():270-275. PubMed ID: 28390976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of mouse models of infection with aerosolized Brucella melitensis and Brucella suis.
    Smither SJ; Perkins SD; Davies C; Stagg AJ; Nelson M; Atkins HS
    Clin Vaccine Immunol; 2009 May; 16(5):779-83. PubMed ID: 19321692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal immunization with Urease loaded N-trimethyl Chitosan nanoparticles elicits high protection against Brucella melitensis and Brucella abortus infections.
    Abkar M; Fasihi-Ramandi M; Kooshki H; Lotfi AS
    Immunol Lett; 2018 Jul; 199():53-60. PubMed ID: 29548705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
    Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
    Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
    Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
    Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R; Francia M; Ciuchini F
    Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
    Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
    Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of specific cell-mediated immune responses and protection in BALB/c mice by vaccination with outer membrane vesicles from a Brucella melitensis human isolate.
    Bagheri Nejad R; Yahyaraeyat R; Es-Haghi A; Nayeri Fasaei B; Zahraei Salehi T
    APMIS; 2019 Dec; 127(12):797-804. PubMed ID: 31514254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.
    Wang Y; Bai Y; Qu Q; Xu J; Chen Y; Zhong Z; Qiu Y; Wang T; Du X; Wang Z; Yu S; Fu S; Yuan J; Zhen Q; Yu Y; Chen Z; Huang L
    Vet Microbiol; 2011 Aug; 151(3-4):354-62. PubMed ID: 21530111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.
    Estein SM; Cassataro J; Vizcaíno N; Zygmunt MS; Cloeckaert A; Bowden RA
    Microbes Infect; 2003 Feb; 5(2):85-93. PubMed ID: 12650766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.